Plain-English translation of NCT06155032 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing whether an emergency procedure called endovascular therapy—which removes blood clots from major arteries in the brain—can help people who had a mild stroke but are experiencing sudden worsening. Some participants will receive this clot-removal procedure along with standard stroke care, while others will receive only standard medical care alone. The study will follow 272 patients across about 30 hospitals in China over roughly two years.
Most studies of emergency clot-removal procedures have focused on people with severe strokes, and the procedures have traditionally been done within the first 24 hours. This trial exists to understand whether this treatment can also help people with mild strokes that are getting worse, even when they come to the hospital more than 24 hours after the stroke started.
You likely qualify if…
You likely don't qualify if…
If you join this study, you will be randomly assigned to either receive the emergency clot-removal procedure plus standard stroke medications, or to receive standard stroke medications alone. You will have seven follow-up visits over 90 days: on the day of enrollment, at 24 hours, 48 hours, 72 hours, around 7 days, and at 30 and 90 days. During these visits, doctors will perform neurological exams, take blood tests, and use imaging scans to see how your brain is healing and how well you are recovering.
AI-generated summary from trial data · Jun 13, 2026 · Not medical advice
China